Year : 2009  |  Volume : 51  |  Issue : 4  |  Page : 254--260

Current perspectives in the treatment of resistant schizophrenia


RK Solanki, Paramjeet Singh, Deepti Munshi 
 Department of Psychiatry, Psychiatry Center, SMS Medical College, Jaipur, India

Correspondence Address:
R K Solanki
D-840, Malviya Nagar, Jaipur - 302 017
India

This article summarizes the current knowledge base on the diagnosis and management of treatment resistant schizophrenia. While the prevalence of treatment resistant schizophrenia is definition dependent, estimates have ranged from 30% to up to 60%. This article first looks into the various diagnostic criteria of treatment resistant schizophrenia. Then the literature is reviewed about the pharmacotherapeutics of its management. Clozapine emerges to be the gold standard. In addition risperidone and high dose olanzapine also emerge as clinically useful options. Other emerging adjunctive treatment options are equally addressed.


How to cite this article:
Solanki R K, Singh P, Munshi D. Current perspectives in the treatment of resistant schizophrenia.Indian J Psychiatry 2009;51:254-260


How to cite this URL:
Solanki R K, Singh P, Munshi D. Current perspectives in the treatment of resistant schizophrenia. Indian J Psychiatry [serial online] 2009 [cited 2021 Sep 24 ];51:254-260
Available from: https://www.indianjpsychiatry.org/article.asp?issn=0019-5545;year=2009;volume=51;issue=4;spage=254;epage=260;aulast=Solanki;type=0